Hyderabad-based Viyash Scientific Ltd, formerly known as Sequent Scientific Ltd, has announced the acquisition of a 100% stake in Italian company BioForLife Italia Srl for a cash consideration of approximately Rs 188 crore. The agreement was signed through its wholly owned subsidiary Alivira Animal Health Ltd, and the deal is expected to close in the second quarter of financial year 2026-27.
Strategic Entry into Italy
This acquisition marks Viyash’s strategic entry into Italy, one of Europe’s five largest animal health markets and a fast-growing hub for companion animal care. BioForLife develops, commercialises, and distributes pet care products, with established positions in nutritional complements, pharmaceuticals, and rapid diagnostic tests. The company is also building a presence in faster-growing specialties such as dermatology and ophthalmology.
Expanding European Footprint
The acquisition strengthens Alivira’s European footprint, which has been expanding through acquisitions across Europe, Latin America, and Asia over the past decade. The move supports Viyash’s push to capitalise on the expanding companion animal health generics opportunity.
Platform for Growth
Viyash stated that the deal will create a platform to introduce products from Alivira’s pipeline into Italy, while also enabling the expansion of BioForLife’s range into other Alivira markets across Europe, the Middle East, Asia, and Latin America. Dr. Haribabu Bodeputi, managing director and group CEO of Viyash Scientific, said: “This acquisition represents another important step in our strategy to build a leading global companion animal health business.” He highlighted the combination of BioForLife’s commercial reach and Alivira’s product development capabilities.
Operational Continuity
BioForLife’s executives will continue to run operations of the Italian company. Its front-end commercial organisation reaches more than 80% of veterinary clinics in Italy, providing broad customer access and relationships that can support future launches.
Growing Companion Animal Segment
Italy’s companion animal segment has been growing rapidly, driven by higher pet ownership, increasing “pet humanisation,” and rising spending on preventive and specialised veterinary care, according to Viyash.
